Zymeworks to Receive an Undisclosed Amount From Merck & Co., Inc. (MRK), Part of a $187 Million Alliance
4/16/2013 7:14:07 AM
More...
|
Zymeworks Raises $11 Million, Hits Antibody Drug Milestone for Merck & Co., Inc. (MRK)
9/6/2012 7:57:01 AM
More...
|
Zymeworks Announces the Formation of its Therapeutics Advisory Team, and Appointment of VP, Preclinical R&D to Advance its Strategic Therapeutics Initiative
1/5/2012 6:24:20 AM
More...
|
Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs
9/22/2011 6:39:36 AM
More...
|
Zymeworks Snags $187 Million Deal With Merck & Co., Inc. (MRK) to Discover Multi-Pronged Antibodies
8/29/2011 7:15:40 AM
More...
|
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
6/29/2010 6:26:04 AM
More...
|
Zymeworks Appoints Computational Antibody Design Expert Dr. Bruce Tidor to its Scientific Advisory Board
10/2/2009 8:31:42 AM
More...
|
Zymeworks Closes $3.5 Million Round of Financing and Announces Changes to its Board of Directors
6/22/2009 8:46:10 PM
More...
|
Zymeworks and XOMA (US) LLC (XOMA) to Collaborate on Antibody Research Program
5/15/2009 11:07:03 AM
More...
|
Zymeworks Awarded BIOTECanada's Gold Leaf Award as Early Stage Company of the Year
5/13/2009 10:14:23 AM
More...
|
|